Med

SJR Rank #381H-index: 52SJR: 4.341Best quartile: Q1APC: US$9,350
Journal website: aims, scope and author guidelines
Publisher

Cell Press

Country

United States

Type

journal

SJR by Edition

2022202502468

Subject Categories

  • Medicine (miscellaneous)Q1

Areas: Medicine

Most published research topics

Cancer Immunotherapy and BiomarkersSARS-CoV-2 and COVID-19 ResearchCAR-T cell therapy researchCOVID-19 Clinical Research StudiesImmunotherapy and Immune ResponsesImmune Cell Function and InteractionGut microbiota and healthvaccines and immunoinformatics approachesCancer Genomics and DiagnosticsLung Cancer Treatments and Mutations

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs090180270360

Documents per Year

20222025050100150200

Detailed Information

ISSN

2666-6359, 2666-6340

SJR Best Quartile

Q1

Region

Northern America

Citations per Document (2 years)

7.56

References per Document

43.47

Coverage

2020-2026

Scope

Med is a flagship clinical and translational research monthly journal published by Cell Press, the global publisher of trusted and authoritative science journals including Cell, Chem, and Joule. Our mission is to accelerate translation of bench research to the clinic by providing a communication forum for the exchange of knowledge, fresh ideas, and thought-leadership among translational researchers, clinicians, and Biotech and Pharma scientists as well as other medical research stakeholders. Our goal is to sustainably and ethically improve health globally. Med publishes rigorously vetted original research and state-of-the-art Review and Perspective articles across the translational and clinical continuum. Our translational research articles are deeply rooted in understanding disease mechanisms, with demonstrable functional impact and broad transformative insights. Our clinical studies cover case reports, first-in-human studies, and large-scale clinical trials, including phase IV, which have the potential to change the course of medical research and improve clinical practice. We are interested in research with likely immediate impact on clinical therapy. These include clinical studies, translational research papers addressing disease mechanism and/or therapies, biotechnology and engineering advances with important clinical impact, and resources (such as informational databases) of broad medical utility.

Metrics from SCImago Journal Rank 2025. View on SCImago